医疗机构科技成果作价投资模式探索——以瑞金医院与T集团药物知识产权作价投资项目为例  

Exploration of pricing investment model for scientific and technological achievements in medical institutions:taking Ruijin Hospital and T Group′s drug patent pricing investment project as an example

作　　者：曹青 廖芬 凌月 计菁[3] 林靖生[1] Cao Qing;Liao Fen;Ling Yue;Ji Jing;Lin Jingsheng(Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Guangci Sinan Technology Transformation Service Center,Shanghai 200025,China;Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)

机构地区：[1]上海交通大学医学院附属瑞金医院,上海200025 [2]广慈-思南技术转化服务中心,上海200025 [3]上海交通大学医学院,上海200025

出　　处：《中华医学科研管理杂志》2024年第5期396-401,共6页Chinese Journal of Medical Science Research Management

基　　金：管理学部国家自然基金(72104143);上海市2023年度"科技创新行动计划"科技成果转化服务体系建设项目(23ZC2620200);上海市2023年度"科技创新行动计划"长三角科技创新共同体领域项目(23002440100)。

摘　　要：目的以瑞金医院与T集团药物专利作价投资项目为例,探讨产医融合创新基地在公立医院作价投资试点实施中的重要意义及医疗机构在促进科技成果转化和生物医药产业持续高速发展中的作用。方法本文通过梳理近年相关的政策文件和管理规范,并查阅知网刊登的相关文献,总结科技成果作价投资转化过程中所遇到的瓶颈问题及解决方案。分析瑞金医院与T集团药物专利作价投资项目实施流程,探讨医疗机构作价投资的运行模式和可行路径。结果作价投资模式在促进科技成果的有效转化、激发科研人员积极参与科技创新和转化的热情方面具有重要意义。在学术创业实践中也面临诸多挑战,如科技成果评估要素复杂、收益分配存在多种复杂状况等问题。因此,医疗机构在开展作价投资时需深入分析市场需求,评估技术成熟度和应用前景,构建专业的团队和制定有效的管理机制,以及关注相关政策的动态,合理规避法律和财务相关风险。结论医疗机构作价投资是实现科技成果转化的有效途径之一,有助于建立医疗机构与企业间的长期稳定合作关系,促进生物医药产业和医疗机构的双向融合发展,推动医学科技类成果快速市场化。ObjectiveThis article took the investment project of using T Group′s drug patents to value invest in Ruijin Hospital as an example,exploring the significance of the integration of production and medicine innovation base in the implementation of valuation investment pilot in public hospitals and the role of medical institutions in promoting the transformation of scientific and technological achievements and the continuous high-speed development of the biopharmaceutical industry.MethodsBy sorting the policies and regulations issued by national and local departments in recent years,and reviewing literature and real cases related to the transformation of scientific and technological achievements in medical institutions in the past five years,an analysis was conducted.ResultsBased on an exploratory case study of the National Major Science and Technology Infrastructure for Translational Medicine(Shanghai),strategies and suggestions were proposed to promote the transformation of scientific and technological achievements in new research and development institutions.ConclusionsThrough the establishment of a professional transfer office team in a scientific research and development and verification platform mainly based on large scientific facilities,and the construction and governance of a scientific and technological achievements transformation system in a hospital park close transformation mode,it is more conducive to the transformation of high-value scientific and technological achievements,the promotion of the two-way integration and development of the biopharmaceutical industry and medical institutions,and the facilitation of the rapid marketization of medical scientific and technological achievements.

关 键 词：产医融合 知识产权作价投资 医学 科技成果转化 

分 类 号：R197.323[医药卫生—卫生事业管理]